Ecat, Julieta .

HRN: 05-20-50  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/04/2023
05/10/2023
IV
1.5 G
Q24hours
Cervical Mass Prob Sec Fo Metastatic Colon Cancers/P Explore Lap, Diverting Colostomy
Waiting Final Action 
05/09/2023
CEFTRIAXONE 1G (VIAL)
05/09/2023
05/16/2023
IV
2 Grams
OD
Cervical Mass Prob Sec To Metastatic Colon Cancers/ P Explore Lap, Diverting Colostomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: